Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Clinical trial NCT01009593 · TERMINATED

Trial details

NCT number: NCT01009593
Sponsor: Abbott
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-resectable Hepatocellular Carcinoma Recurrent Carcinoma, Hepatocellular Liver Diseases Neoplasms by Histologic Type Digestive System Neoplasms Carcinoma Liver Neoplasms Neoplasms Neoplasms by Site Digestive System Diseases Adenocarcinoma

Start date: 2010-01-01
Primary completion: 2012-07-01
Enrollment: 1035

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.